Debby Reuveni Selected Research

Debby Reuveni Research Topics

2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2021 - 01/2018
2	Myasthenia Gravis 01/2020 - 02/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 02/2016
2	Neoplasms (Cancer) 01/2017 - 04/2010
2	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 11/2014 - 12/2012
2	Carcinoma (Carcinomatosis) 08/2010 - 04/2010
1	Inflammation (Inflammations) 01/2021
1	Cholangitis 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Anemia 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Muscle Weakness 11/2014

2	AntigensIBA 01/2020 - 11/2014
2	Moxifloxacin (Avelox)FDA Link 08/2010 - 04/2010
1	Interleukin-23 (Interleukin 23)IBA 01/2021
1	CytokinesIBA 01/2021
1	AntibodiesIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	muskIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	AutoantibodiesIBA 11/2014
1	Cholinergic ReceptorsIBA 11/2014
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2014
1	Etoposide (VP 16)FDA LinkGeneric 08/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2010
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2010
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2010